Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Age-Related Macular Degeneration

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Age-Related Macular Degeneration in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thampi, P1
Rao, HV1
Mitter, SK1
Cai, J1
Mao, H1
Li, H1
Seo, S1
Qi, X1
Lewin, AS1
Romano, C1
Boulton, ME1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Age-Related Macular Degeneration

ArticleYear
The 5HT1a receptor agonist 8-Oh DPAT induces protection from lipofuscin accumulation and oxidative stress in the retinal pigment epithelium.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aged; Aged, 80 and over; Animals; Antioxidants; Cell Line; C

2012